The St. Kitts and Nevis Citizenship Programme has opened a private, appointment-only Biometric Enrolment Suite in central London, giving citizens ...
CEO Richard J. Hutchinson to Join "SHOP 'til You Drop" Healthcare Panel on September 9Bonita Springs, Florida--(Newsfile Corp. - September 8, 2026) - Discovery Senior Living ("Discovery" or "DSL"), on ...
Solusec has earned CREST accreditation, which the international body introduced in July 2026.Albrighton, Shropshire--(Newsfile Corp. - September 8, 2026) - Solusec has been named in the first cohort o ...
New research finds nearly two-thirds of organizations remain in the early stages of resilience maturity as gaps between intelligence, response, and continuous improvement limit progress Everbridge ...
New self-service options give users more control when building physician and provider audiencesKansas City, Missouri--(Newsfile Corp. - September 8, 2026) - MCH Strategic Data, a provider of business- ...
The UN human rights chief has added his voice to growing calls for greater controls on artificial intelligence, warning that the revolutionary technology could become an ...
The antipodean currencies such as the Australia and New Zealand dollars weakened against their major currencies in the European session on Tuesday, amid escalating Middle East ...
The largest commercial carbon capture and storage project in Europe has started its operations in the Dutch village of Sluikil.CO2 will be transported by ship and permanently ...
Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) ("Aurania" or the "Company") is pleased to announce that drilling has commenced at ...
Chairman of the Board of Directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027 Hovione Holding AG today announ ...
Molecular Instruments (MI), founded by the inventor of HCR technology, today announced the availability of HCR Gold IF on Biocare Medical's ONCORE Pro X, a fully open automated slide staining system f ...
OST-HER2-treated patients vs. 45.8% comparable combined historical control (p = 0.002)The two remaining patients who have not yet reached the 3-year timepoint from enrollment ...